Is NEPH research on Rallies investment advice?

No. Rallies provides research, data, and educational context for NEPH. It does not provide personalized investment advice.

NEPH (Nephros Inc.) Stock Analysis - Financials

Nephros Inc. (NEPH) is a publicly traded Healthcare sector company. As of August 25, 2026, NEPH trades at $4.57 with a market cap of $44.31M and a P/E ratio of 40.27. NEPH moved +3.63% today. Year to date, NEPH is -9.63%; over the trailing twelve months it is +5.50%. Its 52-week range spans $1.39 to $6.42. Analyst consensus is buy with an average price target of $6.38. Rallies surfaces NEPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are NEPH's key financials?

NEPH financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NEPH recently traded at $4.57. Market cap is $44.31M. P/E ratio is 40.27. Revenue is $18.79M.

NEPH Key Metrics

Key financial metrics for NEPH
Metric	Value
Price	$4.57
Market Cap	$44.31M
P/E Ratio	40.27
EPS	$0.11
Dividend Yield	0.00%
52-Week High	$6.42
52-Week Low	$1.39
Volume	448
Avg Volume	0
Revenue (TTM)	$18.79M
Net Income	$1.19M
Gross Margin	61.87%

NEPH Analyst Consensus

2 analysts cover NEPH: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.38.

Common questions about NEPH

What are NEPH's key financials?: NEPH financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NEPH recently traded at $4.57. Market cap is $44.31M. P/E ratio is 40.27. Revenue is $18.79M.
Is NEPH research on Rallies investment advice?: No. Rallies provides research, data, and educational context for NEPH. It does not provide personalized investment advice.